Utilizing LabPiQture to uncover or disprove power kidney illness
About 35.5 million folks in the US are presently affected by power kidney illness (CKD), and the prevalence of ensuing kidney failure is rising.1 ExamOne was requested how insurers can rapidly and confidently decide if their applicant has kidney illness. In a latest case research, we present how eGFR outcomes highlighted in LabPiQture TM uncover or disprove power kidney illness.
What’s eGFR?
- In accordance with the Nationwide Kidney Basis, Glomerular filtration charge (GFR) is the most effective total index of kidney perform. 2
- Healthcare suppliers use estimated glomerular filtration charge (eGFR) to find out kidney illness, and in that case, what stage.
- The usual method to estimate eGFR is with a easy blood check.
What worth do eGFR outcomes carry to an underwriter?
- The underwriter will search for the steadiness or conversely the instability of the eGFR to make a potential threat evaluation choice.
How would an underwriter entry this information?
- eGFR outcomes can be highlighted in laboratory testing outcomes supplied via ExamOne’s LabPiQture.
See eGFR leads to motion via LabPiQture.
Be taught extra about how LabPiQture gives essential data concerning CKD and large insights into an applicant’s well being profile.
About LabPiQture
By way of LabPiQture insurers have entry to an intensive medical laboratory database which incorporates physician-ordered laboratory testing outcomes associated to preventative care, illness monitoring, and diagnostic functions. LabPiQture has turn into an integral a part of many underwriting choices. Along with medical laboratory outcomes, detailed data equivalent to analysis codes, LOINC codes and ordering doctor data has confirmed precious. Reinsurers have been actively engaged in learning subsets of deidentified LabPiQture information to judge the effectiveness of this distinctive data supply.
Learn extra research right here.
Â
1Facilities for Illness Management and Prevention. Continual Kidney Illness in the US, 2023 (cdc.gov)